Bayer has closed the acquisition of Roche Consumer Health. From January onwards, the Roche Consumer Health business will become part of the Bayer HealthCare Consumer Care Division, turning Bayer into a leading global over-the-counter (OTC) consumer health organization. The transaction includes the global business of Roche Consumer Health and includes the five Roche Consumer Health production sites in Grenzach (Germany), Gaillard (France), Pilar (Argentinia), Casablanca (Marocco), and Jakarta (Indonesia).
Following the merger, Bayer now ranks among the top three OTC consumer health organizations in the world. "Our vision is to become the best consumer health and wellness company. We know that this is an ambitious, but realistic aspiration", explains Gary S. Balkema, President Consumer Care, adding, "As a combined company, we have many trusted brands such as Aspirin®, Aleve®, Rennie®, Alka-Seltzer®, Bepanthen®, Canesten®, Supradyn® and One-A-Day® which provide a strong foundation for growth in the major OTC segments."
Bayer HealthCare Consumer Care is now present in more than 120 countries and the acquisition has made the division a leader in Europe, has extended its top position in Latin America and has reinforced the company's business in the US and Asia-Pacific.